Coherus BioSciences is a leading biologics platform company focused on delivering high-quality biosimilar therapeutics that may expand patient access to life-changing medicines in regulated markets worldwide. In 2018, the U.S. Food and Drug Administration approved Coherus’ product UDENYCA® (pegfilgrastim-cbqv). For more information, visit www.coherus.com.
333 Twin Dolphin Drive
Redwood City, California 94065